JavaScript Menu Courtesy of Milonic.com
[nucleotide sequence]     [protein sequence]     [ncbi BLAST]     [add construct]     [add ligand annotation]

HR3050E   (TOM1L1)

6 targets assoicated with this target.
HR3050Asibling(1-165)
HR3050Dsibling(197-298)selected
HR3050Fsibling(195-293)selected
HR3050Csibling(1-164)expression tested
HR3050Bsibling(183-295)aggregation screening
HR3050parentHSQC collected and crystal hits

database refs UniProt: Unknown_4585 (Unknown_4585)   |   HUGO: TOM1L1
status X-Ray structure
structures 3RRU (Xray)  
properties length: 142 aa   |   mass: 16.09 kD   |   pI: 8.42   |   ext: 16960   |   organism: Homo sapiens
classes PSI-2, Biomedical: Cancer BioNet T1 (Rutgers), MEGA, Biomedical: Cancer BioNet, BioMedical, PSI-Biology
projects HCPIN    
best PDB match calculating ...
informatics Pxs: 0.159   |   Zn binding sites: no sites identified. CH type (data) CHDE type (data)
domain signatures48464 details   PF00790 details   1.25.40.90 details  
subsequence details   ie 100-200    
BLAST searches

Construct coverage schematic
Display constructs only from this target (HR3050E).
Display constructs associated with this target (HR3050E) and all other associated targets (HR3050, HR3050D, HR3050F, HR3050B, HR3050C, HR3050A).


Domain and UniProt Features
    CATH 1.25.40.90
    SuperFamily 48464
    PFAM PF00790


NESG targets
    HR3050C
    HR3050A
    HR3050E
    HR3050B
    HR3050F
    HR3050D

HR3050

       PDB seq homology



Constructs and Most Advanced Status
   
HR3050-1-159-14.*

   
HR3050C-IDT-14.*

   
HR3050E-14.*

   
HR3050-181-295-14.*

   
HR3050B-IDT-14.*



most recent record
6 years, 28 days ago --     X-Ray structure: 3RRU

2008-12-22    target: HR3050E
2010-03-11    construct: HR3050E-14.3
2010-04-05    expression [ 5, 2 ] : HR3050E-14.3-ss
2010-03-11    construct: HR3050E-14.4
2010-04-05    expression [ 5, 4 ] : HR3050E-14.4-ss
2010-06-08    expression [ 5, 2 ] : HR3050E-14.4-SeMa
2010-11-01    purification [98.8 mg]: HR3050E-14.4-SeMa-GF
2010-11-09     aggregation screening [monomer,18.91 kD,85.1%]
2010-11-04     HR3050E.003 @ Columbia; 2 ml at 7.5 mg/mL
2011-04-30     X-Ray structure: 3RRU (PDB)
2010-11-04     HR3050E.004 @ HWI; 0.45 ml at 7.5 mg/mL
2010-11-04     HR3050E.005 @ Rutgers; 10.5 ml at 7.5 mg/mL
2010-09-15    expression [ 5, 3 ] : HR3050E-14.4-NC5a
2010-09-28    purification [67.0 mg]: HR3050E-14.4-NC5a-GF
2010-11-19     aggregation screening [monomer,20.98 kD,86.7%]
2010-10-06     HR3050E.001 @ Rutgers; 0.4 ml at 1.268 mM
2010-11-17    HSQC [promising]: HR3050E.001.600MHz.20C
2010-10-06     HR3050E.002 @ Rutgers; 0.78 ml at 1.268 mM
2011-03-25     hr3050e.017 @ Rutgers; 0.06 ml at 1.268 mM
2011-03-25     hr3050e.015 @ Rutgers; 0.06 ml at 1.268 mM
2011-03-25     hr3050e.006 @ Rutgers; 0.06 ml at 1.268 mM
2011-03-25     hr3050e.011 @ Rutgers; 0.06 ml at 1.268 mM
2011-03-25     hr3050e.009 @ Rutgers; 0.06 ml at 1.268 mM
2011-03-25     hr3050e.008 @ Rutgers; 0.06 ml at 1.268 mM
2011-03-25     hr3050e.013 @ Rutgers; 0.06 ml at 1.268 mM
2011-03-25     hr3050e.016 @ Rutgers; 0.06 ml at 1.268 mM
2011-03-25     hr3050e.010 @ Rutgers; 0.06 ml at 1.268 mM
2011-03-25     hr3050e.012 @ Rutgers; 0.06 ml at 1.268 mM
2011-03-25     hr3050e.014 @ Rutgers; 0.06 ml at 1.268 mM
2011-03-25     hr3050e.007 @ Rutgers; 0.06 ml at 1.268 mM
2010-10-26    expression [ 5, 3 ] : HR3050E-14.4-SeM-R1
2010-11-01    purification [98.8 mg]: HR3050E-14.4-SeM-R1-GF


Available samples:

SeMet samples
HR3050E.003 @ Columbia HR3050E.005 @ Rutgers HR3050E.004 @ HWI


NC5 samples
hr3050e.010 @ Rutgers hr3050e.016 @ Rutgers
hr3050e.009 @ Rutgers HR3050E.002 @ Rutgers hr3050e.014 @ Rutgers hr3050e.013 @ Rutgers hr3050e.015 @ Rutgers
hr3050e.011 @ Rutgers HR3050E.001 @ Rutgers hr3050e.006 @ Rutgers hr3050e.017 @ Rutgers hr3050e.008 @ Rutgers
hr3050e.007 @ Rutgers hr3050e.012 @ Rutgers